Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

2.7%

2 terminated/withdrawn out of 73 trials

Success Rate

92.6%

+6.0% vs industry average

Late-Stage Pipeline

19%

14 trials in Phase 3/4

Results Transparency

4%

1 of 25 completed trials have results

Key Signals

26 recruiting1 with results

Enrollment Performance

Analytics

N/A
16(34.8%)
Phase 2
14(30.4%)
Phase 4
12(26.1%)
Phase 1
2(4.3%)
Phase 3
2(4.3%)
46Total
N/A(16)
Phase 2(14)
Phase 4(12)
Phase 1(2)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (73)

Showing 20 of 73 trials
NCT07831044Not ApplicableRecruiting

Analysis of Cerebrospinal Fluid Dynamics in Normal Pressure Hydrocephalus

Role: lead

NCT07090577Active Not Recruiting

Multiomics Profiling of CSF in Cardiac Arrest Survivors

Role: lead

NCT07796217Phase 4Recruiting

Comparison of Clopidogrel-based Antiplatelet Agent Treatment and Aspirin Plus Low Dose Rivaroxaban Therapy

Role: collaborator

NCT07754097Recruiting

Self-Management Data and Disease Progression in Chronic Kidney Disease

Role: lead

NCT05827549Phase 2Recruiting

Evaluation of Treatment Efficacy According to Risk Group in Relapsed Childhood Acute Lymphoblastic Leukemia

Role: collaborator

NCT06099366Phase 2Recruiting

Treatment of Newly Diagnosed Standard Risk Acute Lymphoblastic Leukemia in Children

Role: collaborator

NCT06257394Phase 2Recruiting

Treatment of Pediatric Very High-risk Acute Lymphoblastic Leukemia in Korea

Role: collaborator

NCT05148286Phase 4Recruiting

Albumin and Crystalloid Administration in Septic Shock

Role: collaborator

NCT07621458Recruiting

Study on Cutoff Revision Effects and Evaluation of NNT in Primary Aldosteronism

Role: collaborator

NCT06622603Phase 4Recruiting

the Effects of Febuxostat Dose Tapering in Gout Patients Optimally Controlled for 5 Years or More

Role: collaborator

NCT05253118Phase 2Active Not Recruiting

Relapsed or Refractory Primary Diffuse Large B-cell Lymphoma (DLBCL) of the Central Nervous System (CNS)

Role: collaborator

NCT06088121Not ApplicableRecruiting

Study to Evaluate the Efficacy and Safety of ATNC-MDD V1(TMS With Cognitive Training) in Mild Alzheimer's Dementia

Role: collaborator

NCT06330038Phase 4Recruiting

Anesthesia and Non-small Cell Lung Cancer Recurrence

Role: collaborator

NCT06724653Not ApplicableRecruiting

Tapering Heart Failure Medication in Patients With Heart Failure With Recovered Ejection Fraction; Open Label Prospective Random Trial

Role: lead

NCT06519162Recruiting

Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome

Role: lead

NCT05179889Phase 2Recruiting

Adjuvant mFOLFIRINOX for High-risk Stage III Colon Cancer

Role: lead

NCT05884138Not ApplicableRecruiting

Effect of Essential Aminoacid Supplementation and Exercise on Skeletal Muscle Function in Hemodialysis Patients

Role: lead

NCT07481396Recruiting

Molecular Insights Into Post-Cardiac Arrest Brain Injury Via CSF Multi-Omics

Role: lead

NCT04014803Phase 4Recruiting

Aspirin and a PoTent P2Y12 Inhibitor Versus Aspirin and Clopidogrel in Patients Undergoing PCI for Complex Lesion

Role: collaborator

NCT07350187Not ApplicableCompleted

Prospective, Randomized, Controlled Trial Comparing Self-Gripping and Conventional Mesh in Laparoscopic Totally Extra Peritoneal Inguinal Hernia Repair

Role: lead